Flow Cytometry Unit, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Leuk Lymphoma. 2011 Jun;52 Suppl 2:11-3. doi: 10.3109/10428194.2011.570820. Epub 2011 Apr 19.
Flow cytometric immunophenotpying (FCI) is a vital tool in the diagnosis of hairy cell leukemia (HCL). HCL has a distinctive immunophenotype based upon staining with antibodies to CD5 (negative), CD10 (negative), CD23 (negative), CD20 (abnormally bright), CD22 (abnormally bright), CD11c (abnormally bright), CD25 (abnormally bright), CD103 (positive), and CD123 (positive). Due to this unique immunophenotype, FCI can differentiate malignant hairy cells from normal B-cells and other lymphoproliferative disorders, especially the morphologically similar hairy cell leukemia variant and splenic lymphoma with villous lymphocytes. FCI is extremely sensitive in the detection of minimal disease and is useful in monitoring response to therapy.
流式细胞免疫表型分析(FCI)是诊断毛细胞白血病(HCL)的重要工具。HCL 具有独特的免疫表型,基于对 CD5(阴性)、CD10(阴性)、CD23(阴性)、CD20(异常明亮)、CD22(异常明亮)、CD11c(异常明亮)、CD25(异常明亮)、CD103(阳性)和 CD123(阳性)抗体的染色。由于这种独特的免疫表型,FCI 可以将恶性毛细胞与正常 B 细胞和其他淋巴增殖性疾病区分开来,尤其是形态上相似的毛细胞白血病变异型和伴有绒毛状淋巴细胞的脾淋巴瘤。FCI 在检测微小疾病方面非常敏感,并且可用于监测对治疗的反应。